Compare AdaptHealth Corp (AHCO) vs iShares 3 7 Year Treasury Bond ETF (IEI) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

IEI, the iShares 3-7 Year Treasury Bond ETF, trades at $117.20 with minimal daily movement (+0.08%). Technical indicators show a bearish trend with moving averages signaling caution, while oscillators remain neutral. The ETF focuses exclusively on intermediate-term U.S. Treasury debt, offering lower volatility compared to corporate bond alternatives. Recent dividend payments of $0.36-$0.37 demonstrate consistent income distribution to investors.

The outlook for IEI remains heavily dependent on Federal Reserve policy direction amid ongoing inflation concerns. While Treasury-focused ETFs provide safety during market volatility, rising rate expectations pose headwinds for bond prices. The fund's government debt exposure offers stability but may underperform higher-yielding alternatives in a rising rate environment.